Watchlist Price Alert

ALX Oncology Inc. (ALXO)

NASDAQ: ALXO · Real-Time Price · USD

0.44

-0.02 (-4.22%)

At close: May 15, 2025, 3:59 PM

0.44

-0.73%

Pre-market: May 16, 2025, 08:00 AM EDT

ALX Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-134.85M	-160.81M	-123.48M	-83.46M	-45.74M	-19.24M	-13.73M
Depreciation & Amortization	872K	836K	342K	51K	202K	429K	431K
Stock-Based Compensation	27.09M	26.27M	23.84M	13.91M	5.44M	297K	269K
Other Working Capital	-8.41M	7.84M	5.34M	-7.32M	3.99M	1.28M	110K
Other Non-Cash Items	-2.6M	-4.96M	228K	5.42M	295K	11K	2.33M
Deferred Income Tax	n/a	n/a	n/a	n/a	1.27M	n/a	n/a
Change in Working Capital	-12.43M	8.3M	9.85M	-4.03M	247K	4.26M	-159K
Operating Cash Flow	-121.91M	-130.36M	-89.22M	-68.1M	-38.29M	-14.25M	-13.19M
Capital Expenditures	-447K	-1.27M	-1.43M	-4.92M	-31K	-353K	-653K
Cash Acquisitions	n/a	n/a	233.99K	n/a	641K	n/a	n/a
Purchase of Investments	-107.41M	-246.63M	-376.79M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	194.11M	292.56M	142.8M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-233.99K	-4.26M	641K	n/a	n/a
Investing Cash Flow	86.26M	44.66M	-235.42M	-4.92M	610K	-353K	-653K
Debt Repayment	-827K	-388K	9.61M	-281K	-6.51M	5.92M	n/a
Common Stock Repurchased	351K	n/a	336K	202K	n/a	n/a	-6K
Dividend Paid	n/a	n/a	n/a	n/a	-3K	n/a	n/a
Other Financial Acitivies	31.64M	792K	248K	2.75M	n/a	10K	7K
Financial Cash Flow	30.82M	59.29M	9.86M	2.47M	462.88M	15.36M	1K
Net Cash Flow	-4.84M	-26.42M	-314.78M	-70.55M	425.2M	755K	-13.84M
Free Cash Flow	-122.36M	-131.64M	-90.65M	-73.02M	-38.32M	-14.6M	-13.84M